The main transmission route of chronic hepatitis B virus infection is mother-to-child transmission of hepatitis B virus and the main cause of combined immune prophylaxis failure in neonates at the end of pregnancy is high viral load. Moreover, oral administration of nucleos(t)ide analogues (NAs) during the second and third trimesters of pregnancy can significantly reduce or even completely block mother-to-child transmission of HBV. This article focuses on the necessity and feasibility of oral NAs antiviral therapy for HBV carrier pregnant woman with high viral load, and the issues commences at the time of medication and viral load thresholds.
All Keywords
【저자키워드】 therapy, Hepatitis B virus, Mother-to-child transmission, nucleos(t)ide analogues,
【저자키워드】 therapy, Hepatitis B virus, Mother-to-child transmission, nucleos(t)ide analogues,